Join us for this Member's Only 2-Day CLE Webinar Series presented by the Chemical Practice and Biotechnology Committees
Following the wildly successful joint program of the Chemical Practice and Biotechnology Committees at the 2022 AIPLA Spring Meeting in New Orleans, AIPLA and the Committees will host a two-day program where an amazing selection of world-class U.S experts will discuss Hot Topics in Chem and Pharmaceutical U.S. Patent Practice. Day 1 will discuss Duty of Candor, genus and species claims, and Section 101 in chemical/pharma cases. Day 2 will discuss the Amgen v. Sanofi Supreme Court decision, means-plus-function claims in chem and pharma, red-hot legal issues in pharmaceutical labeling, with an emphasis on REMS claims, and obviousness-type double patenting.
Day 1
Moderator: Tom Irving, The Marbury Law Group
Speakers: R. Danny Huntington, Rothwell Figg, Andrea Kamage, Johnson & Johnson. & Paul Browning, Finnegan
Day 2
Moderator: Sherry Knowles, KIPS
Speakers: Sharon Crane, Rothwell Figg, Joanna Brougher, BioPharma Law Group, PLLC, Michelle O'Brien, The Marbury Law Group, & Roy Issac, Bristol-Myers Squibb
AIPLA is an approved provider by most jurisdictions requiring CLE. Each program requires individual jurisdiction approval, and each jurisdiction has different approval guidelines and time frames so programs may not be pre-approved for CLE. Program accreditation is sought in all attendee requested jurisdictions and may be available for up to one year after the original air date. Specialized credits (Ethics, Elimination of Bias, Diversity, Equity & Inclusion, Technology, etc.) approval varies by jurisdiction. CLE reporting and/or certificates of attendance may take up to 4 weeks for processing. For information on CLE accreditation and processing, please contact the AIPLA CLE Department at cle@aipla.org.